Cidara Therapeutics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cidara therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cidara Therapeutics Today - Breaking & Trending Today

Cidara Therapeutics, Inc. (NASDAQ:CDTX) CEO Purchases $105,680.00 in Stock

Cidara Therapeutics, Inc. (NASDAQ:CDTX – Get Free Report) CEO Jeffrey Stein bought 8,000 shares of the company’s stock in a transaction that occurred on Friday, June 7th. The stock was purchased at an average cost of $13.21 per share, with a total value of $105,680.00. Following the acquisition, the chief executive officer now directly owns […] ....

Jeffrey Stein , Needham Company , Cidara Therapeutics Company Profile , Exchange Commission , Cantor Fitzgerald , Cidara Therapeutics Inc , Cidara Therapeutics , Get Free Report , Fire Capital , Free Report , Cidara Therapeutics Daily ,

Contrasting Cidara Therapeutics (NASDAQ:CDTX) and Mesoblast (NASDAQ:MESO)

Cidara Therapeutics (NASDAQ:CDTX – Get Free Report) and Mesoblast (NASDAQ:MESO – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, risk, profitability, valuation, dividends, institutional ownership and analyst recommendations. Insider & Institutional Ownership 35.8% of Cidara Therapeutics […] ....

United States , San Diego , Tasly Pharmaceutical Group , Cidara Therapeutics Inc , Therapeutics Inc , Pharmaceuticals Co , Cidara Therapeutics , Get Free Report , Given Cidara Therapeutic , Cidara Therapeutics Daily ,

Reviewing Cidara Therapeutics (NASDAQ:CDTX) & Mesoblast (NASDAQ:MESO)

Cidara Therapeutics (NASDAQ:CDTX – Get Free Report) and Mesoblast (NASDAQ:MESO – Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, risk, earnings, profitability, institutional ownership, dividends and analyst recommendations. Analyst Ratings This is a summary of current […] ....

San Diego , United States , Pharmaceuticals Co , Cidara Therapeutics Inc , Tasly Pharmaceutical Group , Therapeutics Inc , Cidara Therapeutics , Get Free Report , Given Cidara Therapeutic , Cidara Therapeutics Daily ,

Analysts Set Cidara Therapeutics, Inc. (NASDAQ:CDTX) Price Target at $71.25

Cidara Therapeutics, Inc. (NASDAQ:CDTX – Get Free Report) has been assigned a consensus rating of “Buy” from the four ratings firms that are covering the firm, MarketBeat.com reports. Three investment analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1-year target price […] ....

Cantor Fitzgerald , Raymond James Financial Services Advisors Inc , Cidara Therapeutics Company Profile , Needham Company , Cidara Therapeutics Inc , Cidara Therapeutics , Get Free Report , James Financial Services Advisors , Pale Fire Capital , Get Free , Cidara Therapeutics Daily ,

Head-To-Head Contrast: Cidara Therapeutics (NASDAQ:CDTX) vs. Mesoblast (NASDAQ:MESO)

Cidara Therapeutics (NASDAQ:CDTX – Get Free Report) and Mesoblast (NASDAQ:MESO – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, institutional ownership, dividends, risk, analyst recommendations, earnings and valuation. Institutional & Insider Ownership 35.8% of Cidara Therapeutics […] ....

San Diego , United States , Tasly Pharmaceutical Group , Therapeutics Inc , Cidara Therapeutics Inc , Pharmaceuticals Co , Cidara Therapeutics , Get Free Report , Given Cidara Therapeutic , Cidara Therapeutics Daily ,